Natural Immunoglobulin M (IgM) anti-leukocyte autoantibodies (IgM-ALAs) (Lobo et al., 2017) and A2AR agonists (Li et al., 2012) attenuated AKI by suppressing NKT cells. Here, CD40LG is linked to acute kidney injury.